Study to Assess the Bioavailability of Different Formulations of AZD9977 and Dapagliflozin and Influence of Food in Selected Formulations in Healthy Volunteers

Trial Identifier: D6402C00003
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT04798222
Start Date: June 2021
Primary Completion Date: September 2021
Study Completion Date: September 2021
Condition: Congestive Heart Failure

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
German Translation

Trial Locations

Country Location
Germany Berlin, Germany, 14050